- Home
- PHAR vs AMWD Comparison
PHAR vs AMWD Comparison
Compare PHAR & AMWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- AMWD
- Stock Information
- Founded
- PHAR 1988
- AMWD 1980
- Country
- PHAR Netherlands
- AMWD United States
- Employees
- PHAR N/A
- AMWD N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- AMWD Forest Products
- Sector
- PHAR Health Care
- AMWD Basic Materials
- Exchange
- PHAR Nasdaq
- AMWD Nasdaq
- Market Cap
- PHAR 731.1M
- AMWD 760.7M
- IPO Year
- PHAR N/A
- AMWD N/A
- Fundamental
- Price
- PHAR $10.00
- AMWD $57.00
- Analyst Decision
- PHAR Strong Buy
- AMWD Buy
- Analyst Count
- PHAR 3
- AMWD 4
- Target Price
- PHAR $30.00
- AMWD $83.33
- AVG Volume (30 Days)
- PHAR 3.6K
- AMWD 172.1K
- Earning Date
- PHAR 07-31-2025
- AMWD 08-26-2025
- Dividend Yield
- PHAR N/A
- AMWD N/A
- EPS Growth
- PHAR N/A
- AMWD N/A
- EPS
- PHAR N/A
- AMWD 6.50
- Revenue
- PHAR $320,708,000.00
- AMWD $1,709,585,000.00
- Revenue This Year
- PHAR $13.31
- AMWD N/A
- Revenue Next Year
- PHAR $7.68
- AMWD $4.03
- P/E Ratio
- PHAR N/A
- AMWD $8.74
- Revenue Growth
- PHAR 24.13
- AMWD N/A
- 52 Week Low
- PHAR $6.65
- AMWD $50.00
- 52 Week High
- PHAR $12.61
- AMWD $106.57
- Technical
- Relative Strength Index (RSI)
- PHAR 43.61
- AMWD 55.87
- Support Level
- PHAR $9.99
- AMWD $54.43
- Resistance Level
- PHAR $10.59
- AMWD $58.46
- Average True Range (ATR)
- PHAR 0.35
- AMWD 2.18
- MACD
- PHAR -0.14
- AMWD 0.66
- Stochastic Oscillator
- PHAR 7.45
- AMWD 80.79
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.